Medical News

RSS

Righttime Medical Care outlines common health concerns linked to cold temperatures

Righttime Medical Care, a leading urgent care provider, has been seeing an increase in injuries related to the record-breaking East coast cold weather and offers advice on keeping safe.

23 Feb 2015

Valeant Pharmaceuticals agrees to acquire Salix Pharmaceuticals

Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. today announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158.00 per share in cash, or a total enterprise value of approximately $14.5 billion.

23 Feb 2015

Smartphones, tablets can do damage to overall health in unexpected ways

Despite the many benefits of having information at your fingertips, smartphones and tablets can do damage to your body and overall health in unexpected ways.

21 Feb 2015

Shire announces completion of NPS Pharma acquisition

Shire plc announces the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals, Inc. and the subsequent acquisition of NPS Pharma.

21 Feb 2015

MD Anderson awarded more than $22 million in research grants from CPRIT

The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas. Approximately half of the funds awarded for Individual Investigator Research Awards went to MD Anderson faculty as well as 40 percent of total IIRA awards that include those for children's and adolescent cancer and early detection and prevention.

21 Feb 2015

Researchers reveal new understanding of pathobiology behind vestibular schwannoma

Researchers from the Eaton-Peabody Laboratories of Massachusetts Eye and Ear and the Harvard Medical School/ Massachusetts Institute of Technology Program in Speech and Hearing Bioscience and Technology have revealed new understanding of the pathobiology behind a head and neck tumor that may someday lead to new methods of targeted drug therapy.

21 Feb 2015

Rush University Medical Center earns three-star rating for lung cancer surgery program

Surgery to remove localized tumors is the only reliable way to cure lung cancer, the most prevalent cause of cancer-related deaths in both men and women. The most common operation performed to remove these cancers is a lobectomy (removal of an anatomic portion of lung). Thoracic surgeons at Rush University Medical Center perform the largest number of these operations of any surgical group in Chicago and in most cases use minimally invasive techniques that speed recovery.

21 Feb 2015

New Duke-NUS-led study identifies super-potent antibody that can neutralize dengue virus

A new Duke-NUS-led study has identified a super-potent antibody which requires a minute amount to neutralize the dengue virus.

21 Feb 2015

Mayo Clinic researchers identify molecule that lays groundwork for development of pancreatic cancer

A research team led by investigators from Mayo Clinic's campus in Jacksonville, Florida, and the University of Oslo, Norway, have identified a molecule that pushes normal pancreatic cells to transform their shape, laying the groundwork for development of pancreatic cancer -- one of the most difficult tumors to treat.

21 Feb 2015

International phase 2/3 trial shows Gardasil 9 vaccine protects against nine HPV types

Approximately 12,000 women are diagnosed with cervical cancer each year in the United States and another 4,000 die annually from the disease. However, most cervical cancers are preventable through immunization against the human papillomavirus (HPV). A pivotal international phase 2/3 clinical trial involving Moffitt Cancer Center faculty demonstrated that vaccination with Gardasil 9 protects against nine HPV types, seven of which cause most cases of cervical, vulvar, and vaginal disease.

21 Feb 2015

Discovery could help scientists treat heart problems

The average heart beats 35 million times a year - 2.5 billion times over a lifetime. Those beats must be precisely calibrated; even a small divergence from the metronomic rhythm can cause sudden death. For decades, scientists have wondered exactly how the heart stays so precisely on rhythm even though it contains so many moving parts.

21 Feb 2015

Palbociclib extends progression-free survival in advanced breast cancer patients

Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast cancer patients, including those whose disease has stopped responding to traditional endocrine treatments.

21 Feb 2015

Physiotherapy Associates, Performance Health partner to deliver TheraBand Active Care System

Physiotherapy Associates, a leading provider of outpatient physical rehabilitation, today announced a partnership with Performance Health to deliver the TheraBand Active Care System. Performance Health manufactures TheraBand, Biofreeze and other market leading rehabilitation and wellness brands.

21 Feb 2015

Neuronetrix announces FDA approval of COGNISION System for clinical use

Neuronetrix today announced that it has received 510(k) clearance (K141316) from the United States Food and Drug Administration to market the COGNISION System for clinical use.

21 Feb 2015

Tandem Diabetes Care announces release of t:simulator App

Tandem Diabetes Care, Inc., a medical device company and manufacturer of the t:slim and t:flex Insulin Pumps, today announced the release of the t:simulator App, which mimics the touchscreen interface and features of the t:slim Insulin Pump.

21 Feb 2015

Actavis obtains final approval from FDA for generic Subutex

Actavis plc today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for a generic version of Reckitt Benckiser's Subutex (Buprenorphine 2 mg and 8 mg sublingual tablets).

21 Feb 2015

Discoveries by WA research team offer further treatment hope for victims of stroke

A West Australian research team has made a series of discoveries which may help to minimise the damage that a stroke can cause.

20 Feb 2015

Jenx recognised as an Investor in People

Sheffield-based Jenx Ltd, which employs over 70 people, has become one of the world's most respected companies dedicated to developmental furniture for children. Every day they apply their expertise in paediatric therapy and innovative design to finding better ways to help children with special postural support needs.

20 Feb 2015

Betaretrovirus may infect patients with primary biliary cirrhosis

In a new study published in Alimentary Pharmacology & Therapeutics, researchers at the University of Alberta's Faculty of Medicine & Dentistry have shown that a betaretrovirus which resembles a mouse mammary tumor virus infects patients with the rare liver disease, primary biliary cirrhosis (PBC).

20 Feb 2015

Palatin introduces clinical trial website in support of bremelanotide phase 3 study for FSD treatment

Palatin Technologies, Inc., a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs and commercial potential, today announced that it has launched a clinical trial website in support of its phase 3 reconnect study with bremelanotide for the treatment of female sexual dysfunction (FSD).

20 Feb 2015

Medical News

Righttime Medical Care outlines common health concerns linked to cold temperatures

Valeant Pharmaceuticals agrees to acquire Salix Pharmaceuticals

Smartphones, tablets can do damage to overall health in unexpected ways

Shire announces completion of NPS Pharma acquisition

MD Anderson awarded more than $22 million in research grants from CPRIT

Researchers reveal new understanding of pathobiology behind vestibular schwannoma

Rush University Medical Center earns three-star rating for lung cancer surgery program

New Duke-NUS-led study identifies super-potent antibody that can neutralize dengue virus

Mayo Clinic researchers identify molecule that lays groundwork for development of pancreatic cancer

International phase 2/3 trial shows Gardasil 9 vaccine protects against nine HPV types

Discovery could help scientists treat heart problems

Palbociclib extends progression-free survival in advanced breast cancer patients

Physiotherapy Associates, Performance Health partner to deliver TheraBand Active Care System

Neuronetrix announces FDA approval of COGNISION System for clinical use

Tandem Diabetes Care announces release of t:simulator App

Actavis obtains final approval from FDA for generic Subutex

Discoveries by WA research team offer further treatment hope for victims of stroke

Jenx recognised as an Investor in People

Betaretrovirus may infect patients with primary biliary cirrhosis

Palatin introduces clinical trial website in support of bremelanotide phase 3 study for FSD treatment

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News